Cargando…
PPARγ Mediates the Anti-Epithelial-Mesenchymal Transition Effects of FGF1(ΔHBS) in Chronic Kidney Diseases via Inhibition of TGF-β1/SMAD3 Signaling
Podocytes are essential components of the glomerular basement membrane. Epithelial-mesenchymal-transition (EMT) in podocytes results in proteinuria. Fibroblast growth factor 1 (FGF1) protects renal function against diabetic nephropathy (DN). In the present study, we showed that treatment with an FGF...
Autores principales: | Wang, Dezhong, Zhao, Tianyang, Zhao, Yushuo, Yin, Yuan, Huang, Yuli, Cheng, Zizhao, Wang, Beibei, Liu, Sidan, Pan, Minling, Sun, Difei, Wang, Zengshou, Zhu, Guanghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209477/ https://www.ncbi.nlm.nih.gov/pubmed/34149434 http://dx.doi.org/10.3389/fphar.2021.690535 |
Ejemplares similares
-
FGF1(ΔHBS) prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK/Nur77 suppression
por: Wang, Dezhong, et al.
Publicado: (2021) -
FGF1(ΔHBS) ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation
por: Wang, Dezhong, et al.
Publicado: (2019) -
Correction: FGF1(ΔHBS) ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation
por: Wang, Dezhong, et al.
Publicado: (2023) -
Smad3 Mediates Diabetic Dyslipidemia and Fatty Liver in db/db Mice by Targeting PPARδ
por: He, Huijun, et al.
Publicado: (2023) -
PPAR-δ in Vascular Pathophysiology
por: Wang, Nanping
Publicado: (2008)